Literature DB >> 20467325

Preeclampsia and future maternal health.

David M Carty1, Christian Delles, Anna F Dominiczak.   

Abstract

Preeclampsia is a multisystem disorder that complicates 3-8% of pregnancies in the Western world, and is a major source of morbidity and mortality worldwide. Although it is a disease unique to pregnancy, evidence has mounted in recent years that preeclampsia has important implications for future maternal health, in particular cardiovascular health. In this review we examine epidemiological evidence for this relationship, and examine potential mechanisms such as insulin resistance, genetic factors and endothelial dysfunction that may explain the relationship. In addition we explore potential future avenues of research into the field, such as genomics, proteomics and metabolomics.

Entities:  

Mesh:

Year:  2010        PMID: 20467325     DOI: 10.1097/HJH.0b013e32833a39d0

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  26 in total

1.  Genetic variants, immune function, and risk of pre-eclampsia among American Indians.

Authors:  Lyle G Best; Melanie Nadeau; Kylie Davis; Felicia Lamb; Shellee Bercier; Cindy M Anderson
Journal:  Am J Reprod Immunol       Date:  2011-10-17       Impact factor: 3.886

2.  The MDM2 promoter T309G polymorphism was associated with preeclampsia susceptibility.

Authors:  Saeedeh Salimi; Abbas Mohammadpour-Gharehbagh; Mahnaz Rezaei; Mojtaba Sajadian; Batool Teimoori; Atefeh Yazdi; Mojgan Mokhtari; Minoo Yaghmaei
Journal:  J Assist Reprod Genet       Date:  2017-05-15       Impact factor: 3.412

3.  Effect of chorionic villus sampling on the occurrence of preeclampsia and gestational hypertension: An updated systematic review and meta-analysis.

Authors:  Ahmet Başaran; Mustafa Başaran; Betül Topatan; James N Martin
Journal:  J Turk Ger Gynecol Assoc       Date:  2016-01-12

Review 4.  Preeclampsia and hypertensive disease in pregnancy: their contributions to cardiovascular risk.

Authors:  Carolina Valdiviezo; Vesna D Garovic; Pamela Ouyang
Journal:  Clin Cardiol       Date:  2012-03       Impact factor: 2.882

5.  The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention.

Authors:  Liona C Poon; Andrew Shennan; Jonathan A Hyett; Anil Kapur; Eran Hadar; Hema Divakar; Fionnuala McAuliffe; Fabricio da Silva Costa; Peter von Dadelszen; Harold David McIntyre; Anne B Kihara; Gian Carlo Di Renzo; Roberto Romero; Mary D'Alton; Vincenzo Berghella; Kypros H Nicolaides; Moshe Hod
Journal:  Int J Gynaecol Obstet       Date:  2019-05       Impact factor: 3.561

6.  Long-Term Risk to Develop Hypertension in Women With Former Preeclampsia: A Longitudinal Pilot Study.

Authors:  Chahinda Ghossein-Doha; Marc Spaanderman; Sander M J van Kuijk; Abraham A Kroon; Tammo Delhaas; Louis Peeters
Journal:  Reprod Sci       Date:  2014-01-18       Impact factor: 3.060

7.  Identification of differential gene expression profiles in placentas from preeclamptic pregnancies versus normal pregnancies by DNA microarrays.

Authors:  Tao Meng; Haiying Chen; Manni Sun; He Wang; Ge Zhao; Xiaoshuang Wang
Journal:  OMICS       Date:  2012-06

Review 8.  Mechanisms and management of hypertension in pregnant women.

Authors:  Catherine M Brown; Vesna D Garovic
Journal:  Curr Hypertens Rep       Date:  2011-10       Impact factor: 5.369

9.  Trimester-specific plasma exosome microRNA expression profiles in preeclampsia.

Authors:  Eric Devor; Donna Santillan; Sabrina Scroggins; Akshaya Warrier; Mark Santillan
Journal:  J Matern Fetal Neonatal Med       Date:  2019-01-30

Review 10.  Pre-eclampsia part 2: prediction, prevention and management.

Authors:  Tinnakorn Chaiworapongsa; Piya Chaemsaithong; Steven J Korzeniewski; Lami Yeo; Roberto Romero
Journal:  Nat Rev Nephrol       Date:  2014-07-08       Impact factor: 28.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.